Literature DB >> 33578505

Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination.

Giuseppe Lippi1, Laura Sciacovelli2, Tommaso Trenti3, Mario Plebani2.   

Abstract

Entities:  

Keywords:  COVID-19; antibodies; coronavirus; vaccine

Year:  2021        PMID： 33578505     DOI： 10.1515/cclm-2021-0038

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  8 in total

1.  Assessment of salivary antibody response to BNT162b2 mRNA COVID-19 vaccination.

Authors:  Ivana Lapić; Dragana Šegulja; Dunja Rogić
Journal:  J Med Virol       Date:  2021-05-28       Impact factor: 20.693

2.  Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA.

Authors:  Elisa Danese; Martina Montagnana; Gian Luca Salvagno; Matteo Gelati; Denise Peserico; Laura Pighi; Simone de Nitto; Brandon M Henry; Stefano Porru; Giuseppe Lippi
Journal:  J Med Biochem       Date:  2021-09-03       Impact factor: 3.402

3.  Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers.

Authors:  Gian Luca Salvagno; Brandon M Henry; Giovanni di Piazza; Laura Pighi; Simone de Nitto; Damiano Bragantini; Gian Luca Gianfilippi; Giuseppe Lippi
Journal:  J Med Biochem       Date:  2021-09-03       Impact factor: 3.402

4.  Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination.

Authors:  Gian Luca Salvagno; Brandon M Henry; Giovanni di Piazza; Laura Pighi; Simone De Nitto; Damiano Bragantini; Gian Luca Gianfilippi; Giuseppe Lippi
Journal:  Diagnostics (Basel)       Date:  2021-05-04

5.  Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?

Authors:  Giuseppe Lippi; Brandon Michael Henry; Mario Plebani
Journal:  Diagnostics (Basel)       Date:  2021-05-25

6.  SARS-CoV-2 Infection in Health Workers: Analysis from Verona SIEROEPID Study during the Pre-Vaccination Era.

Authors:  Stefano Porru; Maria Grazia Lourdes Monaco; Angela Carta; Gianluca Spiteri; Marco Parpaiola; Andrea Battaggia; Giulia Galligioni; Beatrice Ferrazzi; Giuliana Lo Cascio; Davide Gibellini; Angelo Peretti; Martina Brutti; Stefano Tardivo; Giovanna Ghirlanda; Giuseppe Verlato; Stefania Gaino; Denise Peserico; Antonella Bassi; Giuseppe Lippi
Journal:  Int J Environ Res Public Health       Date:  2021-06-14       Impact factor: 3.390

7.  Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection.

Authors:  Julien Favresse; Christine Eucher; Marc Elsen; Constant Gillot; Sandrine Van Eeckhoudt; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Microorganisms       Date:  2021-03-08

8.  Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.

Authors:  Julien Favresse; Constant Gillot; Laura Di Chiaro; Christine Eucher; Marc Elsen; Sandrine Van Eeckhoudt; Clara David; Laure Morimont; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Viruses       Date:  2021-07-14       Impact factor: 5.048
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.